Three CAR-T therapies forecasted to capture over 70 per cent of T-Cell immunotherapy market in 2025 Read more
PDC*line Pharma, partners get €8.1mn from Walloon region, BioWin for personalised therapeutic vaccine Read more
Vaccitech begins Phase 1 clinical study of VTP-300 immunotherapeutic to treat chronic Hepatitis B Read more